Although evidences showed that insulin resistance involved in the pathophysiology and treatment of mood and cognition disorders including MDD (22, 23), insulin is known to affect serotonin neurotransmission whose dysfunction will cause behavior and mood disorders, and it was reported that mood alterations during the postpartum period had an obvious decrease in circulating insulin levels (11). This evidence concerns the gene INS and cognitive disorder.